BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3765425)

  • 1. [Familial combined hyperlipidemia. I. Variation in the lipoprotein picture].
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Vnitr Lek; 1986 Sep; 32(9):878-86. PubMed ID: 3765425
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial combined hyperlipidemia. Part I. Lipid values and the lipoprotein pattern.
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Acta Univ Palacki Olomuc Fac Med; 1986; 113():193-216. PubMed ID: 2941985
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined familial hyperlipidemia. Study of a family].
    Ahumada-Ayala M; Lozano-Castañeda O; Rull JA; Valles VE; Wong B
    Rev Invest Clin; 1984; 36(2):141-5. PubMed ID: 6484332
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of genetic variants of familial hyperlipidaemia in some xanthoma patients.
    Gajra B; Talukder G; Panja SK
    Indian J Dermatol; 1981 Jul; 26(3):1-3. PubMed ID: 7348242
    [No Abstract]   [Full Text] [Related]  

  • 5. Status of "familial combined hyperlipidemia".
    Brunzell JD; Motulsky AG
    Prog Clin Biol Res; 1984; 147():403-5. PubMed ID: 6739492
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of familial combined hyperlipidemia in 11 families.
    Das SK; Chandra M; Shukla RN; Nityanand S; Agarwal SS
    Indian J Med Res; 1983 Nov; 78():665-9. PubMed ID: 6671713
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
    Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoprotein fatty acid patterns in various types of familiar combined hyperlipidemia.
    Hrebícek J; Chmela Z; Skottová N; Bartek J; Vecera R
    Acta Univ Palacki Olomuc Fac Med; 1995; 139():19-23. PubMed ID: 8686553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial combined hyperlipidemia. Part II. Clinical picture.
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Acta Univ Palacki Olomuc Fac Med; 1986; 114():243-59. PubMed ID: 2946184
    [No Abstract]   [Full Text] [Related]  

  • 10. [Familial combined hyperlipidemia: detection and characterisation of the hyperlipidemic profile among children and adolescents].
    Ribalta J; La Ville AE; Heras M; Plana N; Masana L
    Med Clin (Barc); 1997 Jun; 109(5):161-4. PubMed ID: 9289537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
    Grundy SM; Vega GL; Yuan Z; Battisti WP; Brady WE; Palmisano J
    Am J Cardiol; 2005 Feb; 95(4):462-8. PubMed ID: 15695129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial combined hyperlipidemia].
    Rubiés-Prat J; Pedro-Botet J
    Med Clin (Barc); 1997 Jun; 109(5):175-6. PubMed ID: 9289540
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymorphism and peripheral levels of apolipoprotein(a) in polygenic hypercholesterolemia and combined hyperlipidemia.
    Shen GX; Mymin D; Dembinski T; Krahn A; Angel A
    Clin Invest Med; 1995 Feb; 18(1):33-41. PubMed ID: 7768064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
    Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial combined hyperlipidemia].
    Bredie SJ; Stalenhoef AF
    Ned Tijdschr Geneeskd; 1996 Dec; 140(50):2528. PubMed ID: 9005339
    [No Abstract]   [Full Text] [Related]  

  • 17. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
    Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary disorders of lipid metabolism, metabolic syndrome and familial combined hyperlipidemia].
    Steinmetz A; Schäfer JR
    Wien Med Wochenschr; 1994; 144(12-13):299-307. PubMed ID: 8650933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-II: active or passive role in familial combined hyperlipidemia.
    Aouizerat BE; Kane JP
    Circ Res; 2003 Jun; 92(11):1179-81. PubMed ID: 12805235
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-density lipoprotein subclass phenotypes and familial combined hyperlipidemia.
    Austin MA
    Diabetes Metab Rev; 1991 Sep; 7(3):173-7. PubMed ID: 1817002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.